Alan L. Landay

Optimizing Viable Leukocyte Sampling from the Female Genital Tract for Clinical Trials: An International Multi-Site Study

R. Kaul, M. McElrath, L. McKinnon, 2014, PloS one.

An approach to the validation of markers for use in AIDS clinical trials.

V. De Gruttola, V. Gruttola, A. Landay, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Serotonin reduction in post-acute sequelae of viral infection

M. Peluso, K. Wellen, A. Greenplate, 2023, Cell.

Gut Microbiota, Plasma Metabolomic Profiles, and Carotid Artery Atherosclerosis in HIV Infection

C. Clish, D. Hanna, H. Hodis, 2022, Arteriosclerosis, thrombosis, and vascular biology.

Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women.

D. Burns, P. Reichelderfer, A. Landay, 2001, The Journal of infectious diseases.

HIV in the female genital tract: viral shedding and mucosal immunity.

A. Landay, L. Al-Harthi, Lena Al-Harthi, 2001, Clinical obstetrics and gynecology.

Can statin preventative treatment inform geroscience‐guided therapeutics?

J. Milic, Alan L. Landay, G. Guaraldi, 2023, Aging cell.

Bacterial vaginosis-associated microflora isolated from the female genital tract activates HIV-1 expression.

A. Landay, K. Roebuck, B. Sha, 1999, Journal of acquired immune deficiency syndromes.